Immuneering/$IMRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Immuneering
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Ticker
$IMRX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
54
ISIN
US45254E1073
Website
Immuneering Metrics
BasicAdvanced
$77M
-
-$1.96
-0.23
-
Price and volume
Market cap
$77M
Beta
-0.23
52-week high
$3.80
52-week low
$1.00
Average daily volume
268K
Financial strength
Current ratio
7.479
Quick ratio
7.021
Long term debt to equity
8.915
Total debt to equity
9.757
Management effectiveness
Return on assets (TTM)
-57.90%
Return on equity (TTM)
-102.48%
Valuation
Price to book
1.83
Price to tangible book (TTM)
2.2
Price to free cash flow (TTM)
-1.252
Growth
Earnings per share change (TTM)
5.44%
3-year earnings per share growth (CAGR)
-2.58%
What the Analysts think about Immuneering
Analyst ratings (Buy, Hold, Sell) for Immuneering stock.
Immuneering Financial Performance
Revenues and expenses
Immuneering Earnings Performance
Company profitability
Immuneering News
AllArticlesVideos
Immuneering to Present at the Jefferies Global Healthcare Conference
GlobeNewsWire·2 weeks ago
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewsWire·1 month ago
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Immuneering stock?
Immuneering (IMRX) has a market cap of $77M as of June 10, 2025.
What is the P/E ratio for Immuneering stock?
The price to earnings (P/E) ratio for Immuneering (IMRX) stock is 0 as of June 10, 2025.
Does Immuneering stock pay dividends?
No, Immuneering (IMRX) stock does not pay dividends to its shareholders as of June 10, 2025.
When is the next Immuneering dividend payment date?
Immuneering (IMRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Immuneering?
Immuneering (IMRX) has a beta rating of -0.23. This means that it has an inverse relation to market volatility.